Wedbush Securities’s Gabelli Healthcare & Wellness Trust GRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-11,232
Closed -$123K 1161
2024
Q3
$123K Buy
11,232
+9
+0.1% +$95 ﹤0.01% 1044
2024
Q2
$108K Buy
11,223
+11
+0.1% +$106 ﹤0.01% 1144
2024
Q1
$115K Buy
11,212
+9
+0.1% +$88 ﹤0.01% 1171
2023
Q4
$105K Buy
11,203
+11
+0.1% +$94 ﹤0.01% 1038
2023
Q3
$96K Buy
11,192
+11
+0.1% +$105 ﹤0.01% 1000
2023
Q2
$111K Buy
11,181
+9
+0.1% +$90 0.01% 1002
2023
Q1
$113K Sell
11,172
-133
-1% -$1.35K 0.01% 1007
2022
Q4
$116K Buy
11,305
+151
+1% +$1.52K 0.01% 977
2022
Q3
$106K Buy
11,154
+9
+0.1% +$100 0.01% 969
2022
Q2
$119K Buy
11,145
+9
+0.1% +$104 0.01% 991
2022
Q1
$143K Buy
11,136
+22
+0.2% +$281 0.01% 1027
2021
Q4
$151K Buy
11,114
+6
+0.1% +$80 0.01% 1091
2021
Q3
$147K Buy
11,108
+739
+7% +$10K 0.01% 1102
2021
Q2
$140K Sell
10,369
-258
-2% -$3.39K 0.01% 1105
2021
Q1
$132K Buy
+10,627
New +$130K 0.01% 1032

Other funds holding GRX

Wedbush Securities's GRX Position: Q4 2024 in Review

Wedbush Securities sold out of Gabelli Healthcare & Wellness Trust (GRX) in Q4 2024, closing a stake of 11,232 shares — an estimated $123K sold.

Wedbush Securities first reported a position in GRX in Q1 2021 and held it in 15 quarters. The position peaked at $151K in Q4 2021. 66 funds tracked by Wall St. Rank hold GRX as of Q4 2024.

  • Wedbush Securities reported no remaining Gabelli Healthcare & Wellness Trust position as of Q4 2024 after selling out during the quarter.
  • Wedbush Securities sold 11,232 Gabelli Healthcare & Wellness Trust shares in Q4 2024, an estimated $123K.
  • Wedbush Securities first reported a position in Gabelli Healthcare & Wellness Trust in Q1 2021 and held it in 15 quarters.
  • Wedbush Securities's Gabelli Healthcare & Wellness Trust position peaked at $151K in Q4 2021.
  • 66 funds tracked by Wall St. Rank held Gabelli Healthcare & Wellness Trust as of Q4 2024.

Based on Wedbush Securities's 13F filing for Q4 2024, filed 13 Feb 2025.